vs

Side-by-side financial comparison of Brown–Forman (BF.B) and Everus Construction Group, Inc. (ECG). Click either name above to swap in a different company.

Brown–Forman is the larger business by last-quarter revenue ($1.0B vs $1.0B, roughly 1.0× Everus Construction Group, Inc.). Brown–Forman runs the higher net margin — 21.6% vs 5.5%, a 16.2% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs -5.4%). Brown–Forman produced more free cash flow last quarter ($107.0M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs -1.6%).

Brown-Forman Corporation is an American family-controlled publicly traded company, one of the largest in the spirits and wine business. Based in Louisville, Kentucky, it manufactures several very well known brands throughout the world, including Jack Daniel's, Old Forester, Woodford Reserve, GlenDronach, BenRiach, Glenglassaugh, Herradura, Korbel, and Chambord. Brown-Forman formerly owned Southern Comfort and Tuaca before selling them off in 2016.

BF.B vs ECG — Head-to-Head

Bigger by revenue
BF.B
BF.B
1.0× larger
BF.B
$1.0B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+38.5% gap
ECG
33.2%
-5.4%
BF.B
Higher net margin
BF.B
BF.B
16.2% more per $
BF.B
21.6%
5.5%
ECG
More free cash flow
BF.B
BF.B
$83.5M more FCF
BF.B
$107.0M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
-1.6%
BF.B

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
BF.B
BF.B
ECG
ECG
Revenue
$1.0B
$1.0B
Net Profit
$224.0M
$55.3M
Gross Margin
59.4%
11.6%
Operating Margin
29.4%
6.8%
Net Margin
21.6%
5.5%
Revenue YoY
-5.4%
33.2%
Net Profit YoY
-13.2%
60.4%
EPS (diluted)
$0.47
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BF.B
BF.B
ECG
ECG
Q4 25
$1.0B
$1.0B
Q3 25
$924.0M
$986.8M
Q2 25
$894.0M
$921.5M
Q1 25
$1.0B
$826.6M
Q4 24
$1.1B
$759.6M
Q3 24
$951.0M
$761.0M
Q2 24
$964.0M
$703.4M
Q1 24
$1.1B
$625.7M
Net Profit
BF.B
BF.B
ECG
ECG
Q4 25
$224.0M
$55.3M
Q3 25
$170.0M
$57.0M
Q2 25
$146.0M
$52.8M
Q1 25
$270.0M
$36.7M
Q4 24
$258.0M
$34.5M
Q3 24
$195.0M
$41.8M
Q2 24
$266.0M
$39.0M
Q1 24
$285.0M
$28.2M
Gross Margin
BF.B
BF.B
ECG
ECG
Q4 25
59.4%
11.6%
Q3 25
59.7%
12.6%
Q2 25
57.4%
13.0%
Q1 25
59.8%
11.2%
Q4 24
59.0%
11.4%
Q3 24
59.4%
11.8%
Q2 24
59.0%
12.6%
Q1 24
59.4%
11.9%
Operating Margin
BF.B
BF.B
ECG
ECG
Q4 25
29.4%
6.8%
Q3 25
28.1%
7.3%
Q2 25
22.9%
7.9%
Q1 25
27.1%
6.2%
Q4 24
31.1%
6.1%
Q3 24
29.5%
7.1%
Q2 24
38.9%
7.3%
Q1 24
34.9%
6.2%
Net Margin
BF.B
BF.B
ECG
ECG
Q4 25
21.6%
5.5%
Q3 25
18.4%
5.8%
Q2 25
16.3%
5.7%
Q1 25
26.1%
4.4%
Q4 24
23.6%
4.5%
Q3 24
20.5%
5.5%
Q2 24
27.6%
5.5%
Q1 24
26.7%
4.5%
EPS (diluted)
BF.B
BF.B
ECG
ECG
Q4 25
$0.47
$1.09
Q3 25
$0.36
$1.11
Q2 25
$0.31
$1.03
Q1 25
$0.57
$0.72
Q4 24
$0.55
$0.68
Q3 24
$0.41
$0.82
Q2 24
$0.56
$0.76
Q1 24
$0.60
$0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BF.B
BF.B
ECG
ECG
Cash + ST InvestmentsLiquidity on hand
$319.0M
Total DebtLower is stronger
$2.4B
$281.5M
Stockholders' EquityBook value
$4.1B
$629.8M
Total Assets
$8.2B
$1.7B
Debt / EquityLower = less leverage
0.59×
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BF.B
BF.B
ECG
ECG
Q4 25
$319.0M
Q3 25
$471.0M
Q2 25
$444.0M
Q1 25
$599.0M
Q4 24
$416.0M
Q3 24
$416.0M
$553.0K
Q2 24
$446.0M
Q1 24
$589.0M
Total Debt
BF.B
BF.B
ECG
ECG
Q4 25
$2.4B
$281.5M
Q3 25
$2.4B
$285.1M
Q2 25
$2.4B
$288.6M
Q1 25
$2.7B
$292.1M
Q4 24
$2.7B
$295.6M
Q3 24
$2.7B
Q2 24
$2.7B
Q1 24
$2.7B
Stockholders' Equity
BF.B
BF.B
ECG
ECG
Q4 25
$4.1B
$629.8M
Q3 25
$4.0B
$573.0M
Q2 25
$4.0B
$514.4M
Q1 25
$3.8B
$460.2M
Q4 24
$3.7B
$422.6M
Q3 24
$3.5B
$453.3M
Q2 24
$3.5B
$490.0M
Q1 24
$3.2B
$464.3M
Total Assets
BF.B
BF.B
ECG
ECG
Q4 25
$8.2B
$1.7B
Q3 25
$8.2B
$1.6B
Q2 25
$8.1B
$1.5B
Q1 25
$8.1B
$1.4B
Q4 24
$8.3B
$1.3B
Q3 24
$8.2B
$1.3B
Q2 24
$8.2B
Q1 24
$8.2B
Debt / Equity
BF.B
BF.B
ECG
ECG
Q4 25
0.59×
0.45×
Q3 25
0.61×
0.50×
Q2 25
0.61×
0.56×
Q1 25
0.70×
0.63×
Q4 24
0.73×
0.70×
Q3 24
0.77×
Q2 24
0.76×
Q1 24
0.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BF.B
BF.B
ECG
ECG
Operating Cash FlowLast quarter
$132.0M
$48.2M
Free Cash FlowOCF − Capex
$107.0M
$23.5M
FCF MarginFCF / Revenue
10.3%
2.3%
Capex IntensityCapex / Revenue
2.4%
2.4%
Cash ConversionOCF / Net Profit
0.59×
0.87×
TTM Free Cash FlowTrailing 4 quarters
$610.0M
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BF.B
BF.B
ECG
ECG
Q4 25
$132.0M
$48.2M
Q3 25
$160.0M
$76.2M
Q2 25
$152.0M
$25.3M
Q1 25
$317.0M
$7.1M
Q4 24
$112.0M
Q3 24
$17.0M
$78.9M
Q2 24
$285.0M
Q1 24
$265.0M
$21.9M
Free Cash Flow
BF.B
BF.B
ECG
ECG
Q4 25
$107.0M
$23.5M
Q3 25
$129.0M
$65.7M
Q2 25
$102.0M
$12.3M
Q1 25
$272.0M
$-11.4M
Q4 24
$81.0M
Q3 24
$-24.0M
$60.9M
Q2 24
$205.0M
Q1 24
$196.0M
$12.6M
FCF Margin
BF.B
BF.B
ECG
ECG
Q4 25
10.3%
2.3%
Q3 25
14.0%
6.7%
Q2 25
11.4%
1.3%
Q1 25
26.3%
-1.4%
Q4 24
7.4%
Q3 24
-2.5%
8.0%
Q2 24
21.3%
Q1 24
18.3%
2.0%
Capex Intensity
BF.B
BF.B
ECG
ECG
Q4 25
2.4%
2.4%
Q3 25
3.4%
1.1%
Q2 25
5.6%
1.4%
Q1 25
4.3%
2.2%
Q4 24
2.8%
Q3 24
4.3%
2.4%
Q2 24
8.3%
Q1 24
6.5%
1.5%
Cash Conversion
BF.B
BF.B
ECG
ECG
Q4 25
0.59×
0.87×
Q3 25
0.94×
1.34×
Q2 25
1.04×
0.48×
Q1 25
1.17×
0.19×
Q4 24
0.43×
Q3 24
0.09×
1.89×
Q2 24
1.07×
Q1 24
0.93×
0.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BF.B
BF.B

Whiskey$771.0M74%
Ready To Drink$138.0M13%
Tequila$67.0M6%
Restofportfolio$52.0M5%
Nonbrandedandbulk$8.0M1%

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

Related Comparisons